The impact of pharmacist-led smoking cessation program at community pharmacy

Yıl 2012, Cilt: 2 Sayı: 1, 20 - 25, 31.01.2014

Leyla Atalay Mesut Sancar , Betul Okuyan Fikret Izzettin

Öz

Objective: It was aimed to retrospectively evaluate the effects of clinical pharmacist-led smoking cessation program directed with nicotine replacement therapy including nicotine gum and nicotine tablet by determining the quitting rate of participants.
Method: This study was conducted between June 2009- June 2010. At the first meeting, the demographic and clinical data were collected and ‘the Fagerstrom Nicotine Addiction Test’ was applied to each participants. The clinical pharmacist informed the participants about the harms of smoking and also advised the appropriate over the counter nicotine replacement products according to each participant’s degree of dependence. Participants were monitored by the pharmacist at regular intervals, either face-to-face or by telephone throughout the 12-month study period. 
Results: The study was conducted on 33 subjects. The mean age of the participants were 41.57±11.90 (range: 24-66). According to the results of the Fagerstrom Nicotine Addiction Test, 15 of them were determined as low nicotine dependent, 9 of them were determined as medium dependent and 9 participants were determined as high dependent. Two patients were lost to follow-up and the study was completed with 31 patients. At the end of the study, it was determined that 64.5% of the 31 participants successfully quitted smoking by the pharmacist-led smoking cessation program at the community pharmacy.
Conclusion: According to these data, it was seen that pharmacists who are the competent and easy to access health care provider should involve in smoking cessation programs.

Key words: Smoking cessation, clinical Pharmacist, nicotine replacement therapy 

Anahtar Kelimeler

-

Bir serbest eczanede eczacı danışmanlığında yürütülen sigara bırakma programının sonuçlarının değerlendirilmesi

Öz

Amaç: Çalışmada, bir serbest eczanede klinik eczacı tarafından yürütülen ‘nikotin replasman tedavisiyle (nikotin sakızı ve nikotin tabletini içeren) sigara bırakma programının bir yıllık sonuçlarının değerlendirilmesi amaçlanmıştır.
Yöntem: Çalışma Haziran 2009 - Haziran 2010 tarihleri arasında gerçekleştirilmiştir. İlk görüşmede katılımcıların demografik ve klinik verileri toplanmış ve her bir katılımcıya ‘Fagerstrom Nikotin Bağımlılık Testi’ uygulanmıştır. Daha sonra klinik eczacı tarafından katılımcılar sigaranın zararları hakkında bilgilendirilmiş ve her bir katılımcının bağımlılık derecesine göre uygun OTC (tezgah üstü ilaç- reçetesiz ilaç) nikotin replasman ürünü tavsiye edilmiştir. Katılımcılar klinik eczacı tarafından on iki ay boyunca yüz yüze veya telefonla yapılan düzenli görüşmelerle takip edilmiştir. 
Bulgular: Çalışmaya katılan 33 katılımcının yaş ortalaması 41.57±11.90 (aralık: 24-66 yıl) olarak hesaplanmıştır. Fagerstrom Nikotin Bağımlılık Testi sonuçlarına göre katılımcıların onbeşinde düşük nikotin bağımlılığı, dokuzunda orta bağımlılık ve kalan dokuz katılımcıda ise yüksek nikotin bağımlılığı saptanmıştır. Hastaların ikisi bir yıllık takipte kaybedilmiş, çalışma 31 hasta ile tamamlanmıştır. Çalışma sonunda, klinik eczacı danışmanlığında serbest eczanede yürütülen sigara bırakma programıyla bir yıl boyunca takip edilen otuz bir katılımcının yirmisinin (%64.5) sigara kullanmayı bıraktığı görülmüştür.
Sonuç: Bu bilgiler ışığında, eğitimli ve kolay ulaşılabilir sağlık mensupları olan eczacıların sigara bırakma programlarında aktif rol almaları gerekmekte olduğu sonucuna ulaşılmıştır.

Anahtar Kelimeler : Sigara bırakma, klinik eczacılık, nikotin replasman tedavisi

Anahtar Kelimeler

Sigara bırakma, klinik eczacılık, nikotin replasman tedavisi

Kaynakça

• McBride PE, Plane MB, Underbakke G, Brown RL, Solberg LI. Smoking screening and management in primary care practices. Arch Fam Med. 1997;6(2):165-72.
• U.S. Department of Health and Human Services, Clinical Practice Guideline Treating Tobacco Use and Dependence: A Report Of Surgeon General 2008 Update, April 2009, Office on Smoking and Health.
• West R, .Shiffman S. Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology Berl 2001;155:115-22.
• Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146.
• Bilir N. Sigarayı bırakma metodları, önemi ve ülkemizdeki durum. In: Tuncer AM, eds. Türkiye’de Kanser Kontrolü, Ankara T.C. Sağlık Bakanlığı Kanserle Savaş Dairesi Başkanlığı, 2007; p.181-185. (http:// ukdk.org/pdf/kitap/13.pdf)
• Hughes J. An algorithm for choosing among smoking cessation treatments. J Subst Abuse Treat. 2008;34(4):426-32.
• Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-27.
• A US Public Health Service report. A clinical practice guideline for treating tobacco use and dependence. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA. 2000;283(24):3244-54.
• A subcommittee of the Research Committee of the British Thoracic Society. Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Br Med J (Clin Res Ed). 1983;286(6365):595-7.
• Tİnnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, Stockner M. Two and four mg nicotine chewing gum and group counselling in smoking cessation: an open, randomized, controlled trial with a 22 month follow-up. Addict Behav. 1988;13(1):17-27.
• Christen AG, McDonald JL Jr, Olson BL, Drook CA, Stookey GK. Efficacy of nicotine chewing gum in facilitating smoking cessation. J Am Dent Assoc. 1984;108(4):594-7.).
• Fagestrom K O. A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med. 1982;5(3):343-51.
• Couchenour RL, Carson DS, Segal AR. Patients’ views of pharmacists as providers of smoking cessation services. J Am Pharm Assoc (Wash). 2002;42(3):510-2.
• Hudmon KS, Hemberger KK, Corelli RL, Kroon LA, Prokhorov AV. The pharmacist’s role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy. J Am Pharm Assoc. 2003;43(5):573-82.).
• Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy. 2007;27(7):1040-51.
• Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43(2):194-201.
• Tran MT, Holdford DA, Kennedy DT, Small RE. Modeling the cost- effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy. 2002;22(12):1623-31.
• Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, Hiscock R. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res. 2011;13(2):135-45.
• Baggarly SA, Jenkins TL, Biglane GC, Smith GW, Smith CM, Blaylock BL. Implementing a referral to telephone tobacco cessation services in Louisiana community pharmacies: a pilot study. Ann Pharmacother. 2010;44(9):1395-402.
• Costello MJ, Sproule B, Victor JC, Leatherdale ST, Zawertailo L, Selby P. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers. Cancer Causes Control. 2011;22(2):167-80.